AlphaMark Advisors’s Colgate-Palmolive CL Stock Holding History

AlphaMark Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$109K	Hold	1,200	–	–	0.05%	168
2024 Q3	$125K	Hold	1,200	–	–	0.04%	253
2024 Q2	$116K	Hold	1,200	–	–	0.04%	267
2024 Q1	$108K	Hold	1,200	–	–	0.04%	265
2023 Q4	$96K	Hold	1,200	–	–	0.04%	276
2023 Q3	$85K	Sell	1,200 -60	-5%	-$4.49K	0.04%	267
2023 Q2	$97K	Hold	1,260	–	–	0.04%	156
2023 Q1	$95K	Hold	1,260	–	–	0.04%	167
2022 Q4	$99K	Hold	1,260	–	–	0.05%	150
2022 Q3	$89K	Sell	1,260 -150	-11%	-$11.8K	0.04%	159
2022 Q2	$113K	Hold	1,410	–	–	0.05%	143
2022 Q1	$107K	Hold	1,410	–	–	0.04%	167
2021 Q4	$120K	Hold	1,410	–	–	0.04%	174
2021 Q3	$107K	Hold	1,410	–	–	0.04%	178
2021 Q2	$115K	Hold	1,410	–	–	0.04%	173
2021 Q1	$111K	Hold	1,410	–	–	0.04%	168
2020 Q4	$121K	Sell	1,410 -189	-12%	-$15.6K	0.05%	148
2020 Q3	$123K	Hold	1,599	–	–	0.05%	135
2020 Q2	$117K	Buy	1,599 +180	+13%	+$12.8K	0.05%	130
2020 Q1	$94K	Hold	1,419	–	–	0.05%	133
2019 Q4	$98K	Hold	1,419	–	–	0.04%	156
2019 Q3	$104K	Hold	1,419	–	–	0.05%	148
2019 Q2	$102K	Hold	1,419	–	–	0.04%	153
2019 Q1	$97K	Hold	1,419	–	–	0.04%	151
2018 Q4	$84K	Sell	1,419 -250	-15%	-$15.6K	0.04%	159
2018 Q3	$112K	Hold	1,669	–	–	0.05%	165
2018 Q2	$108K	Buy	1,669 +9	+0.5%	+$589	0.04%	163
2018 Q1	$119K	Buy	1,660 +8	+0.5%	+$576	0.05%	148
2017 Q4	$125K	Buy	1,652 +8	+0.5%	+$584	0.05%	148
2017 Q3	$120K	Sell	1,644 -54	-3%	-$3.89K	0.05%	137
2017 Q2	$126K	Buy	1,698 +25	+1%	+$1.86K	0.05%	135
2017 Q1	$122K	Buy	1,673 +1,370	+452%	+$95.9K	0.06%	132
2016 Q4	$20K	Hold	303	–	–	0.01%	244
2016 Q3	$22K	Hold	303	–	–	0.01%	193
2016 Q2	$22K	Hold	303	–	–	0.01%	190
2016 Q1	$21K	Buy	303 +53	+21%	+$3.53K	0.01%	186
2015 Q4	$17K	Hold	250	–	–	0.01%	199
2015 Q3	$16K	Hold	250	–	–	0.01%	193
2015 Q2	$16K	Hold	250	–	–	0.01%	213
2015 Q1	$17K	Hold	250	–	–	0.01%	203
2014 Q4	$17K	Sell	250 -150	-38%	-$10.1K	0.01%	210
2014 Q3	$26K	Hold	400	–	–	0.02%	181
2014 Q2	$27K	Hold	400	–	–	0.02%	186
2014 Q1	$26K	Sell	400 -150	-27%	-$9.45K	0.02%	178
2013 Q4	$36K	Hold	550	–	–	0.02%	157
2013 Q3	$33K	Hold	550	–	–	0.02%	167
2013 Q2	$32K	Buy	+550	New	+$32.6K	0.02%	191

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

AlphaMark Advisors's CL Position: Q4 2024 in Review

AlphaMark Advisors held its Colgate-Palmolive (CL) position steady in Q4 2024 at 1,200 shares worth $109K. The position accounts for 0.05% of the portfolio, ranked #168.

AlphaMark Advisors first reported a position in CL in Q2 2013 and has held it in 47 quarters since. The position peaked at $126K in Q2 2017. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.

AlphaMark Advisors held 1,200 shares of Colgate-Palmolive worth $109K as of Q4 2024.
AlphaMark Advisors left its Colgate-Palmolive share count unchanged in Q4 2024.
Colgate-Palmolive made up 0.05% of AlphaMark Advisors's portfolio in Q4 2024, its #168 holding.
AlphaMark Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 47 quarters since.
AlphaMark Advisors's Colgate-Palmolive position peaked at $126K in Q2 2017.
1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.